Table of Contents
Table 5-53: Monroe
Table 5-55: Morgan
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2000 | 1996 - 2000 | 2000 | 1996 - 2000 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 101 | 592.6 | 472 | 563.3 | 42 | 255.3 | 222 | 278.8 |
| Esophagus | * | # | 8 | 9.5** | * | # | 7 | 7.9** |
| Stomach | * | # | 6 | 7.2** | * | # | 2 | # |
| Colon excluding Rectum | 9 | 57.9** | 35 | 45.0 | * | # | 22 | 29.2 |
| Rectum and Rectosigmoid Junction | * | # | 16 | 17.8** | * | # | 2 | # |
| Liver | * | # | 3 | # | * | # | 3 | # |
| Pancreas | * | # | 10 | 11.1** | * | # | 13 | 14.9** |
| Lung and Bronchus | 17 | 102.9** | 81 | 95.7 | 15 | 91.3** | 69 | 85.4 |
| Melanoma of the Skin | * | # | 15 | 18.0** | * | # | 4 | # |
| Prostate | 35 | 198.4 | 153 | 183.2 | * | # | 26 | 35.7 |
| Urinary Bladder | 8 | 46.3** | 32 | 37.9 | * | # | 4 | # |
| Kidney and Renal Pelvis | * | # | 17 | 19.1** | * | # | 6 | 7.1** |
| Brain and Other Nervous System | * | # | 8 | 9.4** | * | # | 9 | 11.0** |
| Non-Hodgkin Lymphoma | 6 | 29.9** | 18 | 19.3** | * | # | 11 | 12.5** |
| Myeloma | * | # | 6 | 7.6** | * | # | 4 | # |
| Leukemia | * | # | 11 | 14.0** | * | # | 7 | 9.5** |
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2000 | 1996 - 2000 | 2000 | 1996 - 2000 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 87 | 392.6 | 412 | 371.9 | 38 | 157.5 | 192 | 163.3 |
| Colon excluding Rectum | 8 | 31.6** | 48 | 40.7 | 6 | 22.9** | 20 | 16.6 |
| Rectum and Rectosigmoid Junction | * | # | 16 | 13.7** | * | # | 9 | 7.8** |
| Liver | * | # | 2 | # | * | # | 5 | 4.1** |
| Pancreas | * | # | 7 | 5.9** | * | # | 8 | 6.5** |
| Lung and Bronchus | 14 | 63.2** | 57 | 50.2 | 6 | 25.0** | 41 | 34.7 |
| Melanoma of the Skin | * | # | 8 | 8.3** | * | # | 2 | # |
| Breast | 22 | 101.0 | 115 | 106.3 | 5 | 19.1** | 22 | 18.2 |
| Cervix Uteri | * | # | 12 | 13.1** | * | # | 5 | 5.3** |
| Corpus Uteri | 8 | 40.2** | 27 | 25.7 | * | # | 3 | # |
| Ovary | 5 | 22.6** | 18 | 16.5** | 5 | 20.7** | 16 | 13.5** |
| Urinary Bladder | * | # | 9 | 7.7** | * | # | 2 | # |
| Kidney and Renal Pelvis | * | # | 16 | 13.1** | * | # | 5 | 4.3** |
| Brain and Other Nervous System | * | # | 6 | 6.2** | * | # | 5 | 4.9** |
| Non-Hodgkin Lymphoma | * | # | 14 | 12.6** | * | # | 11 | 9.0** |
| Myeloma | * | # | 3 | # | * | # | 4 | # |
| Leukemia | * | # | 10 | 8.6** | * | # | 6 | 4.8** |
Rates are per 100,000; Age-adjusted, 2000 U.S. Standard Million.
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than 20 cases are unstable.
# Rate cannot be calculated.
Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, October 2004
Table of Contents
Table 5-53: Monroe
Table 5-55: Morgan
